Increased activity of the complement system in the liver of patients with alcoholic hepatitis

Experimental and Molecular Pathology

Volumn 97, Issue 3, 2014, Pages 338-344

  Shen, Hong ^a   French, Barbara A ^a   Liu, Hui ^a   Tillman, Brittany C ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Alcoholic hepatitis; Complement factors; Inflammation; Mallory Denk bodies

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A RECEPTOR; MESSENGER RNA; ALCOHOL; COMPLEMENT;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; C1Q GENE; C3 GENE; C5 GENE; CELL ORGANELLE; CELLULAR DISTRIBUTION; COMPLEMENT SYSTEM; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL; MALLORY DENK BODY; MORPHOMETRICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; CHEMICALLY INDUCED; COMPLEMENT ACTIVATION; COMPLICATION; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; MALLORY BODY; METABOLISM; PATHOLOGY;

COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; ETHANOL; HEPATITIS, ALCOHOLIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALLORY BODIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84907522167     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.09.004     Document Type: Article

References (35)

1. Bajtay Z., Jozsi M., Banki Z., Thiel S., Thielens N., Erdei A. Mannan-binding lectin and C1q bind to distinct structures and exert differential effects on macrophages. Eur. J. Immunol. 2000, 30:1706-1713.
2. Buchner R.R., Hugli T.E., Ember J.A., Morgan E.L. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J. Immunol. 1995, 155:308-315.
3. Bykov I., Junnikkala S., Pekna M., Lindros K.O., Meri S. Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann. Med. 2006, 38:280-286.
4. Bykov I., Jauhiainen M., Olkkonen V.M., Saarikoski S.T., Ehnholm C., Junnikkala S., Vakeva A., Lindros K.O., Meri S. Hepatic gene expression and lipid parameters in complement C3(-/-) mice that do not develop ethanol-induced steatosis. J. Hepatol. 2007, 46:907-914.
5. Cohen J.I., Roychowdhury S., McMullen M.R., Stavitsky A.B., Nagy L.E. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 2010, 139:664-674. (674 e661).
6. Daveau M., Benard M., Scotte M., Schouft M.T., Hiron M., Francois A., Salier J.P., Fontaine M. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat. J. Immunol. 2004, 173:3418-3424.
7. Fox R.A., Dudley F.J., Sherlock S. The serum concentration of the third component of complement beta-1C-beta-1A in liver disease. Gut 1971, 12:574-578.
8. French S.W. Nature, pathogenesis and significance of the Mallory body. Semin. Liver Dis. 1981, 1:217-231.
9. French S.W., Bardag-Gorce F., Li J., French B.A., Oliva J. Mallory-Denk body pathogenesis revisited. World J. Hepatol. 2010, 2:295-301.
10. Gao B., Jeong W.I., Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008, 47:729-736.
11. Gao B., Seki E., Brenner D.A., Friedman S., Cohen J.I., Nagy L., Szabo G., Zakhari S. Innate immunity in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G516-G525.
12. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 2004, 41:1089-1098.
13. Higuchi H., Kurose I., Kato S., Miura S., Ishii H. Ethanol-induced apoptosis and oxidative stress in hepatocytes. Alcohol. Clin. Exp. Res. 1996, 20:340A-346A.
14. Hillebrandt S., Wasmuth H.E., Weiskirchen R., Hellerbrand C., Keppeler H., Werth A., Schirin-Sokhan R., Wilkens G., Geier A., Lorenzen J., Kohl J., Gressner A.M., Matern S., Lammert F. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet. 2005, 37:835-843.
15. Jarvelainen H.A., Vakeva A., Lindros K.O., Meri S. Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat. Clin. Immunol. 2002, 105:57-63.
16. Koleva M., Schlaf G., Landmann R., Gotze O., Jungermann K., Schieferdecker H.L. Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology 2002, 122:697-708.
17. Liu H., Li J., Tillman B., Morgan T.R., French B.A., French S.W. TLR3/4 signaling is mediated via the NFkappaB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies. Exp. Mol. Pathol. 2014, 97:234-240.
18. MacGregor R.R., Gluckman S.J., Senior J.R. Granulocyte function and levels of immunoglobulins and complement in patients admitted for withdrawal from alcohol. J. Infect. Dis. 1978, 138:747-755.
19. Menon K.V., Gores G.J., Shah V.H. Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin. Proc. 2001, 76:1021-1029.
20. Morgan B.P., Gasque P. Extrahepatic complement biosynthesis: where, when and why?. Clin. Exp. Immunol. 1997, 107:1-7.
21. Nagura H., Hasegawa H., Yoshimura S., Watanabe K. The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis. Acta Pathol. Jpn. 1985, 35:71-78.
22. Oliva J., Dedes J., Li J., French S.W., Bardag-Gorce F. Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically. World J. Gastroenterol. 2009, 15:705-712.
23. Petz L.D. Variable mechanisms for low serum-complement in liver disease. Lancet 1971, 2:1033-1034.
24. Pritchard M.T., McMullen M.R., Stavitsky A.B., Cohen J.I., Lin F., Medof M.E., Nagy L.E. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 2007, 132:1117-1126.
25. Qin X., Gao B. The complement system in liver diseases. Cell. Mol. Immunol. 2006, 3:333-340.
26. Raby A.C., Holst B., Davies J., Colmont C., Laumonnier Y., Coles B., Shah S., Hall J., Topley N., Kohl J., Morgan B.P., Labeta M.O. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur. J. Immunol. 2011, 41:2741-2752.
27. Rensen S.S., Slaats Y., Driessen A., Peutz-Kootstra C.J., Nijhuis J., Steffensen R., Greve J.W., Buurman W.A. Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology 2009, 50:1809-1817.
28. Riedemann N.C., Guo R.F., Ward P.A. A key role of C5a/C5aR activation for the development of sepsis. J. Leukoc. Biol. 2003, 74:966-970.
29. Roychowdhury S., McMullen M.R., Pritchard M.T., Hise A.G., van Rooijen N., Medof M.E., Stavitsky A.B., Nagy L.E. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology 2009, 49:1326-1334.
30. Spagnuolo P.J., MacGregor R.R. Acute thanol effect on chemotaxis and other components of host defense. J. Lab. Clin. Med. 1975, 86:24-31.
31. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., Lambris J.D. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 2003, 198:913-923.
32. Strnad P., Nuraldeen R., Guldiken N., Hartmann D., Mahajan V., Denk H., Haybaeck J. Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models. Compr. Physiol. 2013, 3:1393-1436.
33. Wang H.J., Gao B., Zakhari S., Nagy L.E. Inflammation in alcoholic liver disease. Annu. Rev. Nutr. 2012, 32:343-368.
34. Wlazlo N., van Greevenbroek M.M., Ferreira I., Jansen E.H., Feskens E.J., van der Kallen C.J., Schalkwijk C.G., Bravenboer B., Stehouwer C.D. Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study. Eur. J. Clin. Investig. 2013, 43:679-688.
35. Zatloukal K., French S.W., Stumptner C., Strnad P., Harada M., Toivola D.M., Cadrin M., Omary M.B. From Mallory to Mallory-Denk bodies: what, how and why?. Exp. Cell Res. 2007, 313:2033-2049.